Cargando…

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes

BACKGROUND: To assess the associations of various HbA1c measures, including a single baseline HbA1c value, overall mean, yearly updated means, standard deviation (HbA1c-SD), coefficient of variation (HbA1c-CV), and HbA1c variability score (HVS), with microvascular disease (MVD) risk in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chen-Yi, Su, Pei-Fang, Hung, Jo-Ying, Ou, Huang-Tz, Kuo, Shihchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339461/ https://www.ncbi.nlm.nih.gov/pubmed/32631323 http://dx.doi.org/10.1186/s12933-020-01082-9

Ejemplares similares

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population
por: Jang, Ji-Yong, et al.
Publicado: (2019)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study
por: Yan, Yunyi, et al.
Publicado: (2022)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
por: Fang, Qianhua, et al.
Publicado: (2023)

Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
por: Long, Chen, et al.
Publicado: (2022)

Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus
por: Zhang, Fengping, et al.
Publicado: (2023)

Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes
por: He, Panpan, et al.
Publicado: (2022)

The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes
por: Takao, Toshiko, et al.
Publicado: (2015)

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study
por: Yang, Chun-Ting, et al.
Publicado: (2020)

Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Prediabetes: Adherence to Nutrition Visits Decreases HbA1c in Children and Adolescents
por: Parajuli, Sadichchha, et al.
Publicado: (2022)

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review
por: Yang, Chen-Yi, et al.
Publicado: (2021)

Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function
por: Takenouchi, Akiko, et al.
Publicado: (2016)

Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort
por: Slieker, Roderick C., et al.
Publicado: (2019)

Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes
por: Takenouchi, Akiko, et al.
Publicado: (2015)

Correlation of same-visit HbA1c test with laboratory-based measurements: A MetroNet study
por: Schwartz, Kendra L, et al.
Publicado: (2005)

Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
por: Shen, Yun, et al.
Publicado: (2020)

Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease
por: Gu, Jun, et al.
Publicado: (2019)

Restricted Mean Survival Time Analysis to Estimate SGLT2i–Associated Heterogeneous Treatment Effects on Primary and Secondary Prevention of Cardiorenal Outcomes in Patients With Type 2 Diabetes in Taiwan
por: Peng, Zi-Yang, et al.
Publicado: (2022)

Visit-to-visit fasting blood glucose variability and lifetime risk of cardiovascular disease: a prospective study
por: Bi, Jianing, et al.
Publicado: (2021)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI
por: Yang, Chen Die, et al.
Publicado: (2020)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
por: Chang, Kai-Cheng, et al.
Publicado: (2020)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus
por: Hsu, Jung-Chi, et al.
Publicado: (2021)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
por: Su, Hsuan-Yu, et al.
Publicado: (2023)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

Inter-visit variability of conjunctival microvascular hemodynamic measurements in healthy and diabetic retinopathy subjects
por: Khansari, Maziyar M., et al.
Publicado: (2018)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies
por: Yang, Chen-Yi, et al.
Publicado: (2022)

Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes
por: Tang, Xixiang, et al.
Publicado: (2019)

Visit and Between-Visit Interaction Frequency Before and After COVID-19 Telehealth Implementation
por: Nouri, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hvl9gc8u31bndso7g4b2fs19il